Johnson & Johnson Stock - analyst consensus and earnings outlook
18.06.2026 - 13:22:45 | ad-hoc-news.de
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/18/2026, 11:21 UTC. Details in the imprint.
Johnson & Johnson (US4781601046) remains one of the largest diversified healthcare groups worldwide. With no fresh market-moving filings or ad-hoc releases in the past 24 hours, the focus shifts to analyst consensus expectations and the upcoming quarterly report.
All news and analysis on Johnson & Johnson stock
Background, company news and historical market data on Johnson & Johnson are bundled on the ad-hoc-news topic page and the company’s own investor-relations portal.
What consensus data indicate
For Johnson & Johnson, major data aggregators show a broad analyst coverage with a mixed but broadly constructive stance, reflecting the group’s defensive profile and cash-generation capacity. Exact rating splits and targets vary across platforms and houses.
Market services such as MarketWatch and similar portals summarize dozens of recommendations from global banks and brokers for the stock. They typically present an average rating, a range of 12-month price targets and expectations for earnings-per-share growth.
How analysts frame the story
Analyst coverage on Johnson & Johnson commonly highlights three pillars: pharmaceutical growth drivers, medtech expansion and the stability of consumer-health cash flows following past portfolio reshaping. Litigation risks and pricing pressure in key markets remain recurring discussion points.
Against this backdrop, investors often focus on pipeline milestones, margin development and capital-allocation discipline when reading new analyst notes. Dividend continuity and balance-sheet strength are also central to many investment cases.
The product behind the stock
Johnson & Johnson generates revenue across innovative medicines, medical technology and consumer health products. Its portfolio spans therapeutic areas such as oncology and immunology, alongside widely known over-the-counter brands in pain relief, wound care and personal health.
Where the stock trades today
Johnson & Johnson shares trade on the New York Stock Exchange at a current price level in US dollars; investors can obtain up-to-the-minute quotes and trading data via the NYSE and leading financial portals.
Key facts on Johnson & Johnson stock
- Company: Johnson & Johnson Inc.
- ISIN: US4781601046
- WKN: 853260
- Ticker: JNJ
- Venue: NYSE
- Price (as of latest available quote): data in USD from NYSE and major financial portals
- Market cap: large-cap healthcare group in the hundred-billion-dollar range (latest available data)
- Sector / Industry: Health Care - Pharmaceuticals, Biotechnology & Life Sciences; Health Care Equipment & Supplies
- Index membership: Standard & Poor's 500 index, Dow Jones Industrial Average
- Next earnings date: next quarterly report expected on the company’s published financial calendar
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
